Skip to content

Internet-Based Cervical Cytology Screening Program

Internet-Based Cervical Cytology Screening Program

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00658190
Acronym
IBCCSP
Enrollment
175
Registered
2008-04-14
Start date
2003-10-31
Completion date
2013-01-31
Last updated
2015-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Keywords

Cervical cancer, automation, Internet, telecytology

Brief summary

The purpose of this study is to assess whether a system that couples automated screening of Pap Tests with transmission of machine selected digital images, and review by cytologists at a remote location, performs to a clinically effective standard of accuracy.

Detailed description

This clinical study uses the automated screening capabilities of the FocalPoint Primary Screening System (BD) for gynecologic cytology specimens (Pap tests) to allow for automated field of view (FOV) selection, digital image capture, and subsequent Internet-based transmission to a custom designed computer-based image reading station. The system utilizes liquid-based cytology preparations (ThinPrep, SurePath). In such a system, no skilled cytology human resources are necessary at the scanning site, and all expertise can be centralized. Pilot studies showed that the task was feasible to a clinically relevant standard of care. Phase 1 trials on preselected and seeded specimens confirmed this clinical standard. The phase 2 trials extend the concept to a prospectively enrolled population of patients from 2 sites (Walter Reed, Mass General) thereby testing the concept in a population of normal disease prevalence. The final phase 3 will be a larger study with intended use design, siting a screening device at the 121st Army Hospital in Korea and interpreting the specimen images in the US. In addition to the reading of the specimens, the system is designed to give immediate loop closing results back to each specimen's originating point immediate upon completion of the test.

Interventions

None listed

Sponsors

Walter Reed Army Medical Center
CollaboratorFED
U.S. Army Medical Research and Development Command
CollaboratorFED
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Female presenting to clinic for a Pap test for any reason

Exclusion criteria

* Pregnant * Prisoners * Mentally unable to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Cervical cytology abnormal casesAt enrollmentIdentification of abnormalities compared to the initial interpretation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026